Advanced Human Imaging (AHI) AI Stock Analysis

• Market Cap: AU$20.52M
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): -0.93
• Revenue Growth: -43.29%
• EPS Growth: 73.23%
• Country: AU
• Employees: 19
• Sector: Technology
• Sector Strength: 79
• Industry: Software - Application
• EPS (TTM): -0.02
• Shares Outstanding: 280,582,280
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: 0.06
• Price to Book (P/B): 19.14
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 37 Underperform
• Price Target: ―

The overall stock score for Advanced Human Imaging Ltd. is 37, reflecting significant financial weaknesses and valuation concerns. The company's persistent financial losses, high leverage, and negative cash flow position are major detractors. Additionally, the technical analysis shows bearish signals, with an overbought RSI suggesting potential price corrections. Despite a stable share price, the lack of profitability and dividend yield further weaken the stock's appeal.

Advanced Human Imaging Business Overview & Revenue Model

Company Description

Advanced Human Imaging Ltd. (AHI) is a technology company specializing in mobile application-based human imaging solutions. The company operates in the digital health sector, offering advanced body measurement and biometric tracking capabilities through its proprietary technology. AHI's core products leverage smartphone cameras and artificial intelligence to provide users with detailed health and wellness insights, facilitating better personal health management and clinical assessments.

How the Company Makes Money

Advanced Human Imaging Ltd. generates revenue through a combination of licensing its technology, subscription services, and strategic partnerships. The company's primary revenue streams include licensing fees from integrating its imaging solutions into third-party applications and direct consumer subscriptions for its health and wellness applications. Additionally, AHI collaborates with health organizations, fitness companies, and insurers, which further contributes to its earnings through joint ventures and co-branded products. These partnerships allow AHI to expand its market reach and enhance product offerings, providing value to both users and partners.

Advanced Human Imaging Financial Statement Overview

Summary

Advanced Human Imaging Ltd. shows substantial financial challenges, with negative profitability, high leverage, and cash flow difficulties across all financial statements. The income statement reflects persistent losses, the balance sheet indicates high debt levels relative to equity, and cash flow analysis shows inadequate cash generation from operations. These suggest significant financial distress, necessitating strategic improvements in revenue generation, cost management, and capital structure.

Income Statement

The company's income statement shows a troubling trend, with consistently negative gross profit margins and net income. The gross profit margin is negative due to costs exceeding revenue, and the net profit margin has been consistently negative as well. While there is revenue growth from the previous year, it is not sufficient to cover the losses or improve profitability. EBIT and EBITDA margins are also negative, indicating operational inefficiencies. Overall, the income statement reflects poor financial health and a need for significant improvement in revenue generation and cost management.

Balance Sheet

The balance sheet reveals a highly leveraged position with a debt-to-equity ratio that suggests substantial reliance on debt financing. The equity ratio is low, indicating that a smaller portion of the company's assets is financed by the owners. Return on equity is negative due to ongoing losses, further highlighting financial instability. While the company does have assets, the high level of liabilities poses risks to financial health and sustainability. The balance sheet reflects a need for better capital management and reduction of liabilities.

Cash Flow

Cash flow analysis shows negative operating cash flows, indicating the company is not generating enough cash from its core operations to sustain itself. The free cash flow is also negative, exacerbating concerns about liquidity and financial flexibility. The operating cash flow to net income ratio is unfavorable, as is the free cash flow to net income ratio, highlighting cash inefficiencies and the inability to convert earnings into cash. Despite inflows from financing activities, the overall cash flow position remains weak.

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
2.68M	654.84K	257.60K	593.35K	139.86K
	Gross Profit
-3.72M	-4.67M	-3.17M	-9.29M	-3.76M
	EBIT
-3.69M	-12.60M	-21.40M	-11.93M	-5.92M
	EBITDA
-3.10M	-12.04M	-19.55M	-14.80M	-6.09M
	Net Income Common Stockholders
-4.15M	-12.83M	-20.08M	-14.06M	-5.40M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
25.76K	2.10M	6.01M	2.17M	627.30K
	Total Assets
15.20M	8.91M	10.66M	5.42M	2.95M
	Total Debt
2.44M	1.80M	1.16M	2.32M	1.39M
	Net Debt
2.42M	-301.15K	-4.85M	143.77K	766.29K
	Total Liabilities
11.92M	6.88M	2.11M	3.44M	2.49M
	Stockholders Equity
1.75M	2.03M	8.56M	1.98M	462.51K
Cash Flow		Free Cash Flow
-4.75M	-7.43M	-9.95M	-4.13M	-2.76M
	Operating Cash Flow
-4.75M	-7.37M	-9.86M	-4.10M	-2.70M
	Investing Cash Flow
-95.64K	-669.26K	-3.38M	-3.44M	-84.68K
	Financing Cash Flow
2.78M	4.17M	17.08M	9.09M	2.84M

Advanced Human Imaging Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.08
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Neutral
• RSI: Negative
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHI, the sentiment is Negative. The current price of 0.08 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of -50.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AHI.

Advanced Human Imaging Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$11.80B	10.10	-7.47%	2.99%	7.37%	-8.16%
1CG	50 Neutral	AU$8.25M	―	-86.94%	―	26.58%	32.43%
AMX	44 Neutral	AU$20.90M	―	-24.21%	―	-11.35%	-49.13%
HTG	41 Neutral	AU$14.34M	―		―	0.82%	-58.82%
AR9	40 Underperform	AU$17.85M	―	-45.31%	―	-28.80%	32.87%
PFM	38 Underperform	AU$10.91M	―	-25.95%	―	26.33%	31.67%
AHI	37 Underperform	AU$20.52M	―	-219.41%	―	-43.29%	73.23%

Advanced Human Imaging Corporate Events

Advanced Health Intelligence Expands Partnerships and Secures Funding Amid ASX Reinstatement Efforts

Advanced Health Intelligence Ltd has announced several strategic developments for the quarter ending December 31, 2024, including partnerships with Vitall in Canada and Unisure in the UK. These partnerships aim to expand the use of AHI’s Digital Health Assessment tools in health screening and insurance underwriting, respectively. Additionally, AHI has secured USD$4 million in funding from KOR Investments LLC to support its operations and plans to raise a total of AUD$10 million. Despite technical issues delaying the release of its 2024 Annual Report, AHI is working towards resolving these matters to facilitate the reinstatement of its securities on the ASX. The company’s initiatives highlight its commitment to enhancing health assessment technologies and improving industry positioning in the health and insurance sectors.

Advanced Health Intelligence Ltd Announces Proposed Issue of 10 Million Securities

Advanced Health Intelligence Ltd has announced a proposed issue of 10 million ordinary fully paid securities, with the proposed issue date set for May 9, 2025. This strategic move is likely aimed at capitalizing on market opportunities and could strengthen the company’s financial position, potentially impacting its operations and industry standing positively.

Advanced Health Intelligence Ltd Announces Major Securities Issue

Advanced Health Intelligence Ltd has announced a proposed issue of 149,321,978 ordinary fully paid securities, with a planned issue date of December 2, 2025. This move, aimed at enhancing the company’s capital structure, could potentially strengthen its market positioning and provide additional resources for strategic initiatives, impacting stakeholders positively.

Advanced Health Intelligence Secures $4 Million Funding from UAE’s KOR Investments

Advanced Health Intelligence Ltd has secured a USD$4,000,000 convertible note facility from KOR Investments LLC, a UAE-based company, as part of a larger AUD$10,000,000 fundraising effort. This move replaces previous funding plans and will support the company’s continued operations, including its R&D reimbursement submissions. The investment reflects a significant commitment from KOR, positioning AHI to strengthen its financial base and pursue its strategic initiatives.